The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach.
- 1 April 2001
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 5 (2) , 111-114
- https://doi.org/10.1046/j.1526-0968.2001.005002111.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- B-Cell Superantigens: Molecular and Cellular ImplicationsInternational Reviews of Immunology, 1997
- B Cell Superantigens: Potential Modifiers of the Normal Human BCell RepertoireInternational Reviews of Immunology, 1997
- Streptococcal Toxic-Shock Syndrome: Spectrum of Disease, Pathogenesis, and New Concepts in TreatmentEmerging Infectious Diseases, 1995
- Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of PathogenesisAnnals of Internal Medicine, 1994
- Interactions between staphylococcal superantigens and MHC class II moleculesSeminars in Immunology, 1993
- Superantigens of microbial originSeminars in Immunology, 1993
- Superantigens, T Cells, and MicrobesClinical Infectious Diseases, 1992
- Septic Shock Induced by Group a Streptococcal Infection: Clinical and Therapeutic AspectsScandinavian Journal of Infectious Diseases, 1992
- Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.The Journal of Experimental Medicine, 1988
- Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenesNew England Journal of Medicine, 1987